Beam Therapeutics Inc. Earnings Per Share (Basic)
Beam Therapeutics Inc. (BEAM) reported Earnings Per Share (Basic) of -$1.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- Beam Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.18.
- Beam Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.91.
- Beam Therapeutics Inc. earnings per share, basic for the quarter ending 2025-12-31 was $2.37.
- Beam Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.10.
- Beam Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$0.81.
- Beam Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$4.58.
- Beam Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$1.72.
- Beam Therapeutics Inc. earnings per share, basic for fiscal 2022 was -$4.13.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.18 10-Q · filed 2026-08-04 | -$2.09 10-Q · filed 2026-08-04 | $0.26 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||
| 2026-03-31 | -$0.91 10-Q · filed 2026-05-07 | $1.45 derived: net income ÷ weighted average shares · filed 2026-05-07 | $0.36 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||
| 2025-12-31 | $2.37 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.28 derived: net income ÷ weighted average shares · filed 2026-02-24 | $0.29 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.81 10-K · filed 2026-02-24 | ||
| 2025-09-30 | -$1.10 10-Q · filed 2025-11-04 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$3.32 10-Q · filed 2025-11-04 | -$4.41 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||
| 2025-06-30 | -$1.00 10-Q · filed 2026-08-04 | -$2.21 10-Q · filed 2026-08-04 | -$2.23 10-Q · filed 2025-08-05 | -$3.31 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$4.48 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-03-31 | -$1.23 10-Q · filed 2026-05-07 | -$1.24 10-Q · filed 2025-05-06 | -$2.33 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$3.50 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$4.61 derived: net income ÷ weighted average shares · filed 2026-05-07 | |
| 2024-12-31 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$2.26 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$3.37 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$4.58 10-K · filed 2026-02-24 | ||
| 2024-09-30 | -$1.17 10-Q · filed 2025-11-04 | -$2.28 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$3.49 10-Q · filed 2025-11-04 | -$1.75 derived: net income ÷ weighted average shares · filed 2026-02-24 | ||
| 2024-06-30 | -$1.11 10-Q · filed 2025-08-05 | -$2.31 10-Q · filed 2025-08-05 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-02-24 | ||
| 2024-03-31 | -$1.21 10-Q · filed 2025-05-06 | $0.54 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-02-24 | ||
| 2023-12-31 | $1.77 derived: net income ÷ weighted average shares · filed 2026-02-24 | $0.58 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$1.72 10-K · filed 2026-02-24 | ||
| 2023-09-30 | -$1.22 10-Q · filed 2024-11-05 | -$2.30 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$3.63 10-Q · filed 2024-11-05 | -$4.20 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||
| 2023-06-30 | -$1.08 10-Q · filed 2024-08-06 | -$2.41 10-Q · filed 2024-08-06 | -$2.98 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$4.52 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||
| 2023-03-31 | -$1.33 10-Q · filed 2024-05-07 | -$1.88 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$3.44 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$4.46 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||
| 2022-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$2.10 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$3.12 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$4.13 10-K · filed 2025-02-25 | ||
| 2022-09-30 | -$1.56 10-Q · filed 2023-11-08 | -$2.58 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$3.59 10-Q · filed 2023-11-08 | -$4.55 derived: net income ÷ weighted average shares · filed 2024-02-27 | ||
| 2022-06-30 | -$1.02 10-Q · filed 2023-08-08 | -$2.03 10-Q · filed 2023-08-08 | -$2.98 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$3.42 derived: net income ÷ weighted average shares · filed 2024-02-27 | ||
| 2022-03-31 | -$1.01 10-Q · filed 2023-05-10 | -$1.96 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.39 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$3.59 derived: net income ÷ weighted average shares · filed 2024-02-27 | ||
| 2021-12-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.38 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.58 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$5.77 10-K · filed 2024-02-27 | ||
| 2021-09-30 | -$0.42 10-Q · filed 2022-11-07 | -$1.62 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$4.86 10-Q · filed 2022-11-07 | -$6.54 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||
| 2021-06-30 | -$1.23 10-Q · filed 2022-08-09 | -$4.54 10-Q · filed 2022-08-09 | -$6.25 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$7.12 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||
| 2021-03-31 | -$3.35 10-Q · filed 2022-05-09 | -$5.08 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$5.96 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$6.76 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||
| 2020-12-31 | -$1.69 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.44 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$3.15 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$4.19 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$0.69 10-Q · filed 2021-11-08 | -$1.38 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$2.31 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | -$0.69 10-Q · filed 2021-08-10 | -$1.65 10-Q · filed 2021-08-10 | ||||
| 2019-12-31 | -$14.05 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |